Now FDA-Approved

EaseVRx is the first and only FDA-approved at-home immersive virtual reality (VR) pain treatment indicated as an adjunct treatment for chronic lower back pain (cLBP).

Sign up for updates

EaseVRx is the first in a new class of pain treatment

EaseVRx is an at-home immersive virtual reality therapeutic that has been proven to improve the lives of patients experiencing cLBP.

At-home solution
At-home solution

7-minute-a-day, 8-week, self-directed, at-home proven curriculum that reduces patients’ pain and helps patients learn skills for treating pain in the real world.

Proven curriculum
Proven curriculum

Grounded in established pain management principles and engages multiple distinct neurological systems in a way that treats pain.

Clinically validated
Clinically validated

Demonstrated a significant reduction in pain intensity (42%), as well as reductions in pain interference with activity (49%), sleep (52%), mood (56%), and stress (57%) in pivotal RCT (n=188).1

Non-invasive treatment
Non-invasive treatment

Revolutionary technology that is not limited by some of the common side effects of traditional pharmacological intervention or surgery.

EaseVRx is revolutionizing pain treatment through its proven curriculum:

Dynamic Breathing

Indication for Use EaseVRx is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back-pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.

Contraindications

There are no known contraindications.

Reference: EaseVRx Prescribing Information. AppliedVR, Inc.: Van Nuys, CA. 2021.

1. Garcia LM, Birckhead BJ, Krishnamurthy P, et al. An 8-Week Self-Administered At-Home Behavioral Skills-Based Virtual Reality Program for Chronic Low Back Pain: Double-Blind, Randomized, Placebo-Controlled Trial Conducted During COVID-19. J Med Internet Res. 2021;23(2):e26292.